4027-51-4

Usage

Uses

Used in Pharmaceutical Research:
4,4,4-Trifluoro-1-(pyridin-2-yl)butane-1,3-dione is used as a chemical intermediate for the development of pharmaceuticals. Its ability to selectively inhibit certain enzymes makes it a promising candidate for the creation of new drugs.
Used in Agrochemical Research:
In the agrochemical industry, 4,4,4-trifluoro-1-(pyridin-2-yl)butane-1,3-dione is used as a chemical intermediate for the development of new agrochemicals. Its potential to selectively inhibit enzymes can contribute to the creation of more effective and targeted pesticides or herbicides.
Used in Chemical Research:
4,4,4-Trifluoro-1-(pyridin-2-yl)butane-1,3-dione is used as a research compound in the field of chemistry. Its unique properties and potential applications in enzyme inhibition make it an interesting subject for further study and experimentation.

InChI:InChI=1/C9H6F3NO2/c10-9(11,12)8(15)5-7(14)6-3-1-2-4-13-6/h1-4H,5H2

Upstream product

• 1122-62-9 2-acetylpyridine 
• 383-63-1 ethyl trifluoroacetate, 
• 2459-07-6 methyl pyridine-2-carboxylate 
• 421-50-1 1,1,1-trifluoro-2-propanone 

Downstream Products

• 1148055-41-7 C₁₆H₁₂F₃N₃OS 
• 1453810-28-0 6-(cyclohexylmethyl)-4-(trifluoromethyl)-2,2'-bipyridine 
• 1453810-12-2 6-cyclohexyl-3-hydroxy-1-(pyridin-2-yl)-3-(trifluoromethyl)hex-4-yn-1-one 
• 1453810-27-9 6-(4-methoxyphenyl)-4-(trifluoromethyl)-2,2'-bipyridine 
• 1453810-11-1 3-hydroxy-5-(4-methoxyphenyl)-1-(pyridin-2-yl)-3-(trifluoromethyl)pent-4-yn-1-one 
• 1453810-10-0 3-hydroxy-5-phenyl-1-(pyridin-2-yl)-3-(trifluoromethyl)pent-4-yn-1-one 
• 1219483-58-5 4-trifluoromethyl-2-methylthio-6-(pyridin-2-yl)-pyrimidine 
• 522600-24-4 5-pyridin-2-yl-7-trifluoromethyl-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid 

Relevant academic research and scientific papers

High efficiency electroluminescence of orange-red iridium(III) complexes for OLEDs with an EQE over 30%

In this study, three pyrazol-pyridine ligands, 2-(3-methyl-1H-pyrazol-5-yl)pyridine (mepzpy), 2-(3-(trifluoromethyl)-1H-pyrazol-5-yl)pyridine (cf3pzpy), and 2-(3-phenyl-1H-pyrazol-5-yl)pyridine (phpzpy) were successfully synthesized for three orange-red iridium (III) complexes Ir1, Ir2, and Ir3, respectively, in which (2,6-bis(trifluoromethyl)pyridin-4-yl)isoquinoline (BTPIQ) was applied as main ligand. Their single crystals were obtained by vacuum sublimation. They showed distinct photoluminescent emissions at 583 nm with a shoulder peak at 624 nm, with high phosphorescence quantum yields of up to 89%. Organic light-emitting devices (OLEDs) with these complexes as emitters exhibits good performances. Especially, the device with Ir3 complex achieves the best performance with a maximum luminance of 24,188 cd m?2, and a highest external quantum efficiency of 30.65%. This research proved that Ir(III) complexes show highly enhanced performance by the modification of electro-donating benzene ring group into ancillary ligands, which also offers us an efficient strategy to obtain high efficiency orange-red Ir(III) complexes for OLEDs.

Design and synthesis of novel benzenesulfonamide containing 1,2,3-triazoles as potent human carbonic anhydrase isoforms I, II, IV and IX inhibitors

In a quest to discover new biologically active compounds, a series of twenty novel heterocyclic derivatives substituted at position 5 with -H (7a-7j) or -CF3 (8a-8j), bearing benzenesulfonamide at N-1 position and various aroyl groups at position 4 of the 1,2,3-triazole ring was synthesized and screened for their carbonic anhydrase (CA, EC 4.2.1.1) inhibition potential against four human (h) isoforms hCA I, II, IV and IX. All the compounds (7a-7j and 8a-8j) were synthesized via [3+2] cycloaddition reaction from 4-azidobenzenesulfonamide. Interestingly, compounds 7a-7j were prepared in one pot manner via enaminone intermediate using novel methodology. All the newly synthesized compounds (7a-7j & 8a-8j) were found to be excellent inhibitors of edema related isoform hCA I with their inhibition constant (Ki) ranging from 30.1 to 86.8 nM as compared to standard drug acetazolamide (AAZ) with Ki = 250 nM. Further it was found that most of tested compounds were weaker inhibitors of isoform, hCA II although compounds 7b, 7d-7e, 8a, 8d-8f, 8i (mostly with electron withdrawing substituents) have shown better inhibition potential (Ki i = 52.4 nM) than AAZ (Ki = 74 nM) while against tumor associated hCA IX, all the compounds have shown moderate inhibition potential. Present study have added one more step in exploring the 1,2,3-triazlole moiety in the medicinal field.

An SAR study of hydroxy-trifluoromethylpyrazolines as inhibitors of Orai1-mediated store operated Ca2+ entry in MDA-MB-231 breast cancer cells using a convenient Fluorescence Imaging Plate Reader assay

The proteins Orai1 and STIM1 control store-operated Ca2+ entry (SOCE) into cells. SOCE is important for migration, invasion and metastasis of MDA-MB-231 human triple negative breast cancer (TNBC) cells and has been proposed as a target for cancer drug discovery. Two hit compounds from a medium throughput screen, displayed encouraging inhibition of SOCE in MDA-MB-231 cells, as measured by a Fluorescence Imaging Plate Reader (FLIPR) Ca2+ assay. Following NMR spectroscopic analysis of these hits and reassignment of their structures as 5-hydroxy-5-trifluoromethylpyrazolines, a series of analogues was prepared via thermal condensation reactions between substituted acylhydrazones and trifluoromethyl 1,3-dicarbonyl arenes. Structure-activity relationship (SAR) studies showed that small lipophilic substituents at the 2- and 3-positions of the RHS and 2-, 3- and 4-postions of the LHS terminal benzene rings improved activity, resulting in a novel class of potent and selective inhibitors of SOCE.

Highly efficient green electroluminescence of iridium(iii) complexes based on (1: H -pyrazol-5-yl)pyridine derivatives ancillary ligands with low efficiency roll-off

Four iridium(iii) complexes, namely Ir-me, Ir-cf3, Ir-py, and Ir-ph, were synthesized, in which 2-(4-trifluoromethyl)phenylpyridine (tfmppy) was used as the main ligand and 2-(3-methyl-1H-pyrazol-5-yl)pyridine (mepzpy), 2-(3-(trifluoromethyl)-1H-pyrazol-5-yl)pyridine (cf3pzpy), 2,2′-(1H-pyrazole-3,5-diyl)dipyridine (pypzpy), and 2-(3-phenyl-1H-pyrazol-5-yl)pyridine (phpzpy) were applied as ancillary ligands, respectively. All complexes showed similar green light peaking at 494-499 nm with high phosphorescence quantum efficiency (0.76-0.82). The organic light-emitting diodes (OLEDs) with the structure of ITO/HATCN (hexaazatriphenylenehexacabonitrile) (5 nm)/TAPC (bis[4-(N,N-ditolylamino)-phenyl]cyclohexane, 50 nm)/Ir complexes (8 wt%): TCTA (4,4′,4′′-tri(9-carbazoyl)triphenylamine, 20 nm)/TmPyPB (1,3,5-tri[(3-pyridyl)-phen-3-yl]benzene, 40 nm)/LiF (1 nm)/Al (100 nm) displayed high current efficiency with low efficiency roll-off. Moreover, the device based on the Ir-me complex exhibited the best performances with a maximum luminance of 38 155 cd m-2, maximum current efficiency of 92 cd A-1, and a maximum external quantum efficiency of 28.90%. These results suggested that green Ir(iii) complexes were obtained by modification of the ppy ligand and rational introduction of (1H-pyrazol-5-yl)pyridine derivatives as the ancillary ligands for high efficient OLEDs.

Photoluminescence and electroluminescence of four orange-red and red organic iridium(III) complexes

Using 1-(4-(trifluoromethyl)phenyl)isoquinoline (tfmpiq) and 4-(4-(trifluoromethyl)phenyl) quinazoline (tfmpqz) as the main ligands and pyrazole pyridine derivatives (mepzpy: 2-(3-methyl-1H-pyrazol-5-yl)pyridine, cf3pzpy: 2-(3-(trifluoromethyl)-1H-pyrazol

Pyridylpyrazole N∧N ligands combined with sulfonyl-functionalised cyclometalating ligands for blue-emitting iridium(III) complexes and solution-processable PhOLEDs

A series of blue iridium(iii) complexes (12-15) comprising sulfonyl-functionalised phenylpyridyl cyclometalating ligands and pyridylpyrazole N^N ligands are reported, with an X-ray crystal structure obtained for 12. The complexes are highly emissive with photoluminescence quantum yields of 0.52-0.70 in dichloromethane solutions: two of the complexes (12 and 14) show emissions at λPLmax 457 nm which is considerably blue-shifted compared to the archetypal blue emitter FIrpic (λmax 468 nm). The short excited state lifetimes (1.8-3.3 μs) and spectral profiles are consistent with phosphorescence from a mixture of ligand-centred and MLCT excited states. Density functional (DFT) and time dependent DFT (TD-DFT) calculations are in agreement with the electrochemical properties and the blue phosphorescence of the complexes. The additional mesityl substituent on the pyridylpyrazole ligand of 12 and 13 enhances the solubility of the complexes facilitating thin film formation by solution processing. Phosphorescent organic light-emitting diodes (PhOLEDs) have been fabricated using 12 or 13 in a solution-processed single-emitting layer using either poly(vinylcarbazole) (PVK) or 1,3-bis(N-carbazolyl)benzene (mCP) as host. The most blue-shifted electroluminescence (λELmax 460 nm, CIEx,y 0.15, 0.21) is obtained for an OLED containing complex 12 and mCP, with a brightness of 5400 cd m-2 at 10 V which is high for PhOLEDs with similar blue CIE coordinates using a solution-processed emitter layer.

BIDENTATE HETEROLEPTIC SQUARE PLANAR COMPLEXES OF (PYRIDYL)AZOLATES

Bidentate heteroleptic square planar complexes of (pyridyl)azolates possess optical and electrical properties that render them useful for a wide variety of optical and electrical devices and applications. In particular, the complexes are useful for obtain

METAL COMPLEXES COMPRISING CONDENSED HETEROAROMATIC RINGS

The present invention relates inter alia to a new class of heteroleptic metal complexes comprising condensed aromatic heterocyclic rings, their preparation and use.

Sterically Hindered Luminescent PtII-Phosphite Complexes for Electroluminescent Devices

PtII complexes with one bulky, sterically demanding, tertiary phosphite ancillary ligand and a coordinating chromophore are herein presented. The phosphite ligand, tris(2,4-di-tert-butylphenyl) acts as a bidentate ligand coordinating the platin

Interactions of aroyl- and heteroaroyltrifluoroacetones with thiobenzoylhydrazine

The interaction of aroyl(heteroaroyl)trifluoroacetones with thiobenzoylhydrazine may occur at both carbonyl groups. Reaction at the trifluoroacetyl group is facilitated by terminal substituents in the 1,3-dicarbonyl part, which leads can effectively conjugate with the adjacent carbonyl group. The products of condensation at the trifluoroacetyl group are 2-[2-aryl(heteroaroyl)-2-oxoethyl]-5-phenyl-2-trifluoromethyl-2,3-dihydro-1,3, 4-thiadiazoles, while condensation at the aroyl(heteroaroyl)group gave 3-aryl(heteroaryl)-5-hydroxy-1-thiobenzoyl-5-trifluoromethyl-4, 5-dihydro-1H-pyrazoles, which are not prone to tautomeric transformations in solution. 2008 Springer Science+Business Media, Inc.